SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : SANGUINE CORP. (SGNC)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Mr. Forthright who wrote (1274)6/18/1998 7:47:00 PM
From: Andrew H  Read Replies (2) of 5402
 
>>Do you know why rocketeer1 did what he did?<<

Ok, I'll bite, just what did rocketeer1 do?

BTW, have you checked the research thread? Chirodoc has reprinted some interesting information on the company and its product. The product certainly appears to be genuine, although odds remain against them bringing the product to market.

Let's give credit where it is due, they got the funding for animal trials. If it is really 30M as macker says, that is very impressive, although certainly excessive for animal trials and one wonders why they would not report that figure in the release. IF they got 30M for research purposes, they may actually be undervalued at 1, since many biotechs who never get a product through the FDA have a much greater market cap than SGNC.

Let us see how things unfold.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News